These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 25246934)

  • 21. Thiazolidinedione activation of peroxisome proliferator-activated receptor gamma can enhance mitochondrial potential and promote cell survival.
    Wang YL; Frauwirth KA; Rangwala SM; Lazar MA; Thompson CB
    J Biol Chem; 2002 Aug; 277(35):31781-8. PubMed ID: 12082115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective effect of pioglitazone, a PPARγ ligand, in a 3 nitropropionic acid model of Huntington's disease.
    Napolitano M; Costa L; Palermo R; Giovenco A; Vacca A; Gulino A
    Brain Res Bull; 2011 May; 85(3-4):231-7. PubMed ID: 21440606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroprotective effects of PPAR-γ agonist rosiglitazone in N171-82Q mouse model of Huntington's disease.
    Jin J; Albertz J; Guo Z; Peng Q; Rudow G; Troncoso JC; Ross CA; Duan W
    J Neurochem; 2013 May; 125(3):410-9. PubMed ID: 23373812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thiazolidinediones inhibit growth of gastrointestinal, biliary, and pancreatic adenocarcinoma cells through activation of the peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha pathway.
    Tsujie M; Nakamori S; Okami J; Hayashi N; Hiraoka N; Nagano H; Dono K; Umeshita K; Sakon M; Monden M
    Exp Cell Res; 2003 Sep; 289(1):143-51. PubMed ID: 12941612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The macrophage-mediated effects of the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone attenuate tactile allodynia in the early phase of neuropathic pain development.
    Takahashi Y; Hasegawa-Moriyama M; Sakurai T; Inada E
    Anesth Analg; 2011 Aug; 113(2):398-404. PubMed ID: 21490083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
    Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
    Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peroxisome proliferator-activated receptor γ (PPARγ): A master gatekeeper in CNS injury and repair.
    Cai W; Yang T; Liu H; Han L; Zhang K; Hu X; Zhang X; Yin KJ; Gao Y; Bennett MVL; Leak RK; Chen J
    Prog Neurobiol; 2018; 163-164():27-58. PubMed ID: 29032144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Curcumin protects neurons against oxygen-glucose deprivation/reoxygenation-induced injury through activation of peroxisome proliferator-activated receptor-γ function.
    Liu ZJ; Liu HQ; Xiao C; Fan HZ; Huang Q; Liu YH; Wang Y
    J Neurosci Res; 2014 Nov; 92(11):1549-59. PubMed ID: 24975470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The neuroprotective role of rosiglitazone in advanced glycation end product treated human neural stem cells is PPARgamma-dependent.
    Chiang MC; Cheng YC; Nicol CJ; Lin CH
    Int J Biochem Cell Biol; 2017 Nov; 92():121-133. PubMed ID: 28964868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Nuclear Receptor PPARgamma as a Therapeutic Target for Cerebrovascular and Brain Dysfunction in Alzheimer's Disease.
    Nicolakakis N; Hamel E
    Front Aging Neurosci; 2010; 2():. PubMed ID: 20725514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of neuroinflammation in forebrain-specific Cdk5 conditional knockout mice by PPARγ agonist improves neuronal loss and early lethality.
    Utreras E; Hamada R; Prochazkova M; Terse A; Takahashi S; Ohshima T; Kulkarni AB
    J Neuroinflammation; 2014 Feb; 11():28. PubMed ID: 24495352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of cerebral peroxisome proliferator-activated receptors gamma promotes neuroprotection by attenuation of neuronal cyclooxygenase-2 overexpression after focal cerebral ischemia in rats.
    Zhao Y; Patzer A; Herdegen T; Gohlke P; Culman J
    FASEB J; 2006 Jun; 20(8):1162-75. PubMed ID: 16770015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PPARγ as a therapeutic target to rescue mitochondrial function in neurological disease.
    Corona JC; Duchen MR
    Free Radic Biol Med; 2016 Nov; 100():153-163. PubMed ID: 27352979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peroxisome proliferator-activated receptor gamma-independent activation of p38 MAPK by thiazolidinediones involves calcium/calmodulin-dependent protein kinase II and protein kinase R: correlation with endoplasmic reticulum stress.
    Gardner OS; Shiau CW; Chen CS; Graves LM
    J Biol Chem; 2005 Mar; 280(11):10109-18. PubMed ID: 15649892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Axonal PPARγ promotes neuronal regeneration after injury.
    Lezana JP; Dagan SY; Robinson A; Goldstein RS; Fainzilber M; Bronfman FC; Bronfman M
    Dev Neurobiol; 2016 Jun; 76(6):688-701. PubMed ID: 26446277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer).
    Tjokroprawiro A
    Acta Med Indones; 2006; 38(3):160-6. PubMed ID: 17119268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents.
    Tureyen K; Kapadia R; Bowen KK; Satriotomo I; Liang J; Feinstein DL; Vemuganti R
    J Neurochem; 2007 Apr; 101(1):41-56. PubMed ID: 17394460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin Treatment Prevents Neuroinflammation and Neuronal Injury with Restored Neurobehavioral Function in Models of HIV/AIDS Neurodegeneration.
    Mamik MK; Asahchop EL; Chan WF; Zhu Y; Branton WG; McKenzie BA; Cohen EA; Power C
    J Neurosci; 2016 Oct; 36(41):10683-10695. PubMed ID: 27733618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PPARγ regulates the mitochondrial dysfunction in human neural stem cells with tumor necrosis factor alpha.
    Chiang MC; Cheng YC; Lin KH; Yen CH
    Neuroscience; 2013 Jan; 229():118-29. PubMed ID: 23153990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuronal differentiation of embryonic midbrain cells by upregulation of peroxisome proliferator-activated receptor-gamma via the JNK-dependent pathway.
    Park KS; Lee RD; Kang SK; Han SY; Park KL; Yang KH; Song YS; Park HJ; Lee YM; Yun YP; Oh KW; Kim DJ; Yun YW; Hwang SJ; Lee SE; Hong JT
    Exp Cell Res; 2004 Jul; 297(2):424-33. PubMed ID: 15212945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.